Literature DB >> 26130409

Cell-free expression with the toxic amino acid canavanine.

Emanuel G Worst1, Matthias P Exner2, Alessandro De Simone2, Marc Schenkelberger1, Vincent Noireaux3, Nediljko Budisa2, Albrecht Ott4.   

Abstract

Canavanine is a naturally occurring noncanonical amino acid, which is analogous to arginine. It is a potent antimetabolite and natural allelochemic agent, capable of affecting or blocking regulatory and catalytic reactions that involve arginine. Incorporated into proteins at arginine positions, canavanine can be detrimental to protein stability and functional integrity. Although incorporation of canavanine into proteins has long been documented, due to its toxicity, expression in Escherichia coli and other common hosts remains a considerable challenge. Here, we present a simple, cell-free expression system with markedly improved performance compared to heterologous expression. The cell-free expression system does not require any tuning besides substitution of arginine by canavanine. We show that our technique enables highly efficient protein expression in small volumes with arginine being fully replaced by canavanine for functional and structural studies.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimetabolite; Arginine; Canavanine; Cell-free expression; Noncanonical amino acid

Mesh:

Substances:

Year:  2015        PMID: 26130409     DOI: 10.1016/j.bmcl.2015.06.045

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  12 in total

Review 1.  The growing impact of lyophilized cell-free protein expression systems.

Authors:  J Porter Hunt; Seung Ook Yang; Kristen M Wilding; Bradley C Bundy
Journal:  Bioengineered       Date:  2016-10-28       Impact factor: 3.269

2.  Increasing the fidelity of noncanonical amino acid incorporation in cell-free protein synthesis.

Authors:  Qinglei Gan; Chenguang Fan
Journal:  Biochim Biophys Acta Gen Subj       Date:  2016-12-02       Impact factor: 3.770

3.  News Feature: Biology research, no cells required: By borrowing the machinery of life from broken cells, researchers are producing novel proteins, cheap lab reagents, and just-add-water vaccines.

Authors:  David Adam
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-16       Impact factor: 11.205

Review 4.  Biochemistry of Aminoacyl tRNA Synthetase and tRNAs and Their Engineering for Cell-Free and Synthetic Cell Applications.

Authors:  Ragunathan Bava Ganesh; Sebastian J Maerkl
Journal:  Front Bioeng Biotechnol       Date:  2022-07-01

5.  Spatially organizing biochemistry: choosing a strategy to translate synthetic biology to the factory.

Authors:  Christopher M Jakobson; Danielle Tullman-Ercek; Niall M Mangan
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

Review 6.  Exploring the Potential of Cell-Free Protein Synthesis for Extending the Abilities of Biological Systems.

Authors:  Khushal Khambhati; Gargi Bhattacharjee; Nisarg Gohil; Darren Braddick; Vishwesh Kulkarni; Vijai Singh
Journal:  Front Bioeng Biotechnol       Date:  2019-10-11

Review 7.  Escherichia coli Extract-Based Cell-Free Expression System as an Alternative for Difficult-to-Obtain Protein Biosynthesis.

Authors:  Sviatlana Smolskaya; Yulia A Logashina; Yaroslav A Andreev
Journal:  Int J Mol Sci       Date:  2020-01-31       Impact factor: 5.923

8.  Photoactivation of Cell-Free Expressed Archaerhodopsin-3 in a Model Cell Membrane.

Authors:  Navid Khangholi; Marc Finkler; Ralf Seemann; Albrecht Ott; Jean-Baptiste Fleury
Journal:  Int J Mol Sci       Date:  2021-11-05       Impact factor: 5.923

9.  In vitro flow cytometry-based screening platform for cellulase engineering.

Authors:  Georgette Körfer; Christian Pitzler; Ljubica Vojcic; Ronny Martinez; Ulrich Schwaneberg
Journal:  Sci Rep       Date:  2016-05-17       Impact factor: 4.379

10.  Residue-specific Incorporation of Noncanonical Amino Acids into Model Proteins Using an Escherichia coli Cell-free Transcription-translation System.

Authors:  Emanuel G Worst; Matthias P Exner; Alessandro De Simone; Marc Schenkelberger; Vincent Noireaux; Nediljko Budisa; Albrecht Ott
Journal:  J Vis Exp       Date:  2016-08-01       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.